New Study Shows That Four Biomarkers, Including Homocysteine, May Help to Predict the Risk of Stroke
SAN DIEGO, CA – (August 25, 2016) In a recent study, multiple biomarkers were examined to see the relationship between them and stroke.
"People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology."
"Of the 15 biomarkers, four were associated with an increased risk of stroke. People with elevated homocysteine were 32 percent more likely to have a stroke. Those with high vascular endothelial growth factor were 25 percent more likely; those with high ln-C reactive protein were 28 percent more likely; and those with high ln-tumor necrosis factor receptor 2 were 33 percent more likely to have a stroke during the study."
Click below to read the full article
